MT1‐MMP: A tethered collagenase
Open Access
- 24 March 2004
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 200 (1) , 11-19
- https://doi.org/10.1002/jcp.20065
Abstract
Gene ablation in mice offers a powerful tool to assay in vivo the role of selected molecules. Numerous new mouse models of matrix metalloproteinases (MMP) deficiency have been developed in the past 5 years and have yielded a new understanding of the role of MMPs while also putting to rest assumptions based on data predating the days of mouse models. The phenotype of the MT1‐MMP deficient mouse is one example which illustrates the sometimes rather surprising insights into extracellular matrix remodeling in development and growth that can be gained with mouse genetics. While MT1‐MMP appears to play little or no role in embryonic development, loss of this enzyme results in progressive impairment of postnatal growth and development affecting both the skeleton and the soft connective tissues. The underlying pathologic mechanism is loss of an indispensable collagenolytic activity, which remains essentially uncompensated. Our findings demonstrate that growth and maintenance of the skeleton requires coordinated and simultaneous MT1‐MMP‐dependent remodeling of all soft tissue attachments (ligaments, tendons, joint capsules). We note that the phenotype of the MT1‐MMP deficient mouse bears no resemblance to those of mice deficient in MMP‐2 and tissue inhibitors of metallo‐proteinase (TIMP)‐2 all but dispelling the view that activation of MMP‐2 by the MT1‐MMP/TIMP‐2/proMMP‐2 axis plays a significant role in growth and development throughout life. It is of interest to note that loss of a single catabolic function such as selective collagen degradation mediated by MT1‐MMP gives rise to profound impairment of a number of both anabolic and catabolic functions.Keywords
This publication has 40 references indexed in Scilit:
- Enamelysin (Matrix Metalloproteinase 20)-deficient Mice Display an Amelogenesis Imperfecta PhenotypeJournal of Biological Chemistry, 2002
- Matrix metalloproteinases: a tail of a frog that became a princeNature Reviews Molecular Cell Biology, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Cellular Activation of MMP-2 (Gelatinase A) by MT2-MMP Occurs via a TIMP-2-independent PathwayJournal of Biological Chemistry, 2001
- Functional characterization of MT3‐MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3‐D collagen latticeThe FASEB Journal, 2000
- Inactivating Mutation of the Mouse Tissue Inhibitor of Metalloproteinases-2(Timp-2) Gene Alters ProMMP-2 ActivationJournal of Biological Chemistry, 2000
- TIMP-2 Is Required for Efficient Activation of proMMP-2 in VivoJournal of Biological Chemistry, 2000
- In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell MalignancyThe Journal of cell biology, 1998
- Unaltered Secretion of β-Amyloid Precursor Protein in Gelatinase A (Matrix Metalloproteinase 2)-deficient MiceJournal of Biological Chemistry, 1997
- Activation of Progelatinase A and Progelatinase A/TIMP-2 Complex by Membrane Type 2-Matrix MetalloproteinaseBiological Chemistry, 1997